These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Efficacy of atazanavir in treatment-naive patients]. Moreno S; Hernández B; Dronda F Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():9-13. PubMed ID: 20116611 [TBL] [Abstract][Full Text] [Related]
23. [Atazanavir protects lipid metabolism. New PI with favorable metabolic profile]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():90. PubMed ID: 15373065 [No Abstract] [Full Text] [Related]
24. A new protease inhibitor from Bristol-Myers Squibb. TreatmentUpdate; 2001; 12(12):5. PubMed ID: 11570092 [No Abstract] [Full Text] [Related]
25. Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor. Grant P; Taylor J; Cain P; Short W; Gallant J; Farthing C; Thal G; Coakley E; Zolopa A Clin Infect Dis; 2009 Mar; 48(5):680-2. PubMed ID: 19191657 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study. Giuntini R; Martinelli C; Ricci E; Vichi F; Gianelli E; Madeddu G; Abeli C; Palvarini L; Penco G; Marconi P; Grosso C; Pellicano G; Bonfanti P; Quirino T HIV Med; 2010 Jan; 11(1):40-5. PubMed ID: 19686438 [TBL] [Abstract][Full Text] [Related]
27. Report from the 13th retrovirus conference. Extending the role of atazanavir. Feinberg J AIDS Clin Care; 2006 Apr; 18(4):38. PubMed ID: 16718882 [No Abstract] [Full Text] [Related]
32. [Introduction. Usefulness of atazanavir in the treatment of patients infected by human immunodeficiency virus]. Rivero A Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():1. PubMed ID: 20116609 [No Abstract] [Full Text] [Related]
33. Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy. Pavie J; Porcher R; Torti C; Medrano J; Castagna A; Valin N; Rusconi S; Ammassari A; Ghosn J; Delaugerre C; Molina JM; J Antimicrob Chemother; 2011 Oct; 66(10):2372-8. PubMed ID: 21821627 [TBL] [Abstract][Full Text] [Related]